Cytek Biosciences, Inc. — Director's Dealing 2021

Jul 23, 2021

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: Cytek BioSciences, Inc. (CTKB)
CIK: 0001831915
Period of Report: 2021-07-22

Reporting Person: Barnett Valerie (General Counsel)

Holdings (Derivative)

Security	Exercise Price	Expiration	Underlying	Shares	Ownership
Stock Option (Right to Buy)	$4.71	2031-03-22	Common Stock (133330)		Direct

Footnotes

F1: The shares subject to the option vest as follows: 25% of the shares subject to the option vests on January 19, 2022; and 1/48th of the shares subject to the option vest monthly thereafter over the following three years.